Get started
Author

Harold A. Yoon

Hippocampal Avoidance During Whole-Brain Radiotherapy Plus Memantine for Patients With Brain Metastases: Phase III Trial NRG Oncology CC001
2020 · Paul D. Brown, Vinai Gondi, et al. · Journal of Clinical Oncology · 850
PDF
Evaluation of Safety of Stereotactic Body Radiotherapy for the Treatment of Patients With Multiple Metastases
2021 · Steve Chmura, Kathryn A. Winter, et al. · JAMA Oncology · 100
PDF
Phase I Trial of Stereotactic Body Radiation Therapy (SBRT) to Multiple Metastatic Sites: A NRG Oncology Study
2018 · S.J. Chmura, K. Winter, et al. · International Journal of Radiation Oncology*Biology*Physics · 31
Effective treatment of the brachial plexus syndrome in breast cancer patients by early detection and control of loco-regional metastases with radiation or systemic therapy
2009 · Boriana Kamenova, Albert S. Braverman, et al. · International Journal of Clinical Oncology · 22
Primary Endpoint Results of NRG CC003: Phase IIR/III Trial of Prophylactic Cranial Irradiation (PCI) with or without Hippocampal Avoidance (HA) for Small Cell Lung Cancer (SCLC)
2023 · V. Gondi, S. Pugh, et al. · International Journal of Radiation Oncology*Biology*Physics · 20
Hippocampal Avoidance During Prophylactic Cranial Irradiation for Patients With Small Cell Lung Cancer: Randomized Phase II/III Trial NRG-CC003
2025 · Vinai Gondi, Stephanie L. Pugh, et al. · Journal of Clinical Oncology · 19
Ncog-01. Preservation of Neurocognitive Function (ncf) With Hippocampal Avoidance During Whole-brain Radiotherapy (wbrt) for Brain Metastases: Preliminary Results of Phase Iii Trial Nrg Oncology Cc001
2018 · Vinai Gondi, Stephanie Pugh, et al. · Neuro-Oncology · 17
Partial Breast Brachytherapy as the Primary Treatment for Breast Cancer Diagnosed After Mantle Radiation Therapy for Hodgkin's Disease
2009 · Manjeet Chadha, Harold Yoon, et al. · American Journal of Clinical Oncology · 17
Stereotactic Body Radiotherapy vs Moderately Hypofractionated IMRT for Localized Intermediate-Risk Prostate Cancer
2026 · Rodney J. Ellis, Stephanie L. Pugh, et al. · JAMA · 2
“Hope” Drives Quality of Life in Patients With Brain Metastases, But, the “Hope Center” Remains Elusive: An Analysis of NRG-CC003
2025 · Benjamin W. Corn, Rebecca Paulus, et al. · International Journal of Radiation Oncology*Biology*Physics · 2
Actr-50. Preservation of Neurocognitive Function & Patient-reported Symptoms With Hippocampal Avoidance (ha) During Whole-brain Radiotherapy (wbrt) for Brain Metastases: Long-term Results of Nrg Oncology Cc001
2019 · Terri Armstrong, Snehal Deshmukh, et al. · Neuro-Oncology · 2
Hope drives quality of life in patients with brain metastases, but the hope center remains elusive: An analysis of NRG-CC003.
2024 · Benjamin W. Corn, Rebecca Paulus, et al. · Journal of Clinical Oncology · 1
PDF
Impact of Intensified Survivorship Care Planning on Cardiovascular Care in Prostate Cancer Survivors: Primary Results of NRG-CC007CD
2025 · R.C. Chen, S. Pugh, et al. · International Journal of Radiation Oncology*Biology*Physics
Radt-01. Baseline Hippocampal Volume as a Predictor of Neurocognitive Changes After Wbrt or Ha-wbrt: Secondary Analysis of Nrg Oncology Cc001
2023 · Christopher Abraham, Stephanie Pugh, et al. · Neuro-Oncology
PDF
Biom-03. Lack of Correlation of Mr-determined White Matter Injury(wmi)with Neurocognitive Function (ncf)6 Months Following Wbrt+/-hippocampal Avoidance(ha)+memantine:secondary Analysis of Nrg Oncology Nrgcc001
2023 · Joseph Bovi, Stephanie Pugh, et al. · Neuro-Oncology
PDF
Ncog-04. Pretreatment Volume of Mr-determined White Matter Injury (wmi) Predicts Neurocognitive Decline After Hippocampal Avoidant (ha) Wbrt+memantine for Brain Metastases: Secondary Analysis of Nrg Oncologycc001
2020 · Joseph Bovi, Stephanie Pugh, et al. · Neuro-Oncology
PDF
Works count: 16
Citation count: 1,083
H-index: 8
I10-index: 8
Year
Topic
Type